FLGT – fulgent genetics, inc. (US:NASDAQ)

News

Fulgent Genetics (NASDAQ:FLGT) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Fulgent Genetics to Acquire Bako Diagnostics Assets and StrataDx for $55.5 Million [Los Angeles Times (CA)]
Fulgent Genetics to buy Bako Diagnostics assets and StrataDx [Yahoo! Finance]
Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx [Yahoo! Finance]
Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com